Informations sur le produit
SirReal2 is a potential drug target that inhibits the mitochondrial membrane potential. It was identified using a fluorescence probe and an airway smooth muscle cell model. SirReal2 has also been shown to be effective in preventing metabolic disorders, such as low energy and obesity, as well as cancer. The mechanism of action for this drug is unclear, but it may inhibit lysine residues from being modified with acetyl groups.